| A431 | Dermatoma cancer |
| A-549 | Lung cancer |
| AChE | Acetylcholinesterase |
| B16F10 | Melanogenesis activity |
| BEN-MEN-1 | Meningioma |
| BGC-823 | Human gastric carcinoma |
| CAL-27 | Head and neck squamous cell carcinomas |
| CCF-STTG1 | Astrocytoma |
| CHG-5 | Glioma |
| CI | Confidence intervals |
| Detroit-562 | Head and neck squamous cell carcinomas |
| ED50 | Median effective dose |
| F.sp. | Forma specialis, abbreviated f. sp., is an informal taxonomic grouping allowed by the International Code of Nomenclature for algae, fungi, and plants |
| HCT 116 | Human colorectal carcinoma |
| HeLa | Human Gastric cancer |
| Hep-2 | Head and neck squamous cell carcinomas |
| HepG2 | Human hepatocellular |
| HIF-α | Hypoxia-inducible factor |
| HL-60 | Human myeloid leukemia |
| HS-1 | Dermatona cancer |
| HS-4 | Dermatona cancer |
| HT-29 | Human colorectal carcinoma |
| IC50 | Half maximal inhibitory concentration |
| ID50 | Median infective dose |
| IL-1β | Interleukin 1 beta |
| LNCaP | Human prostate carcinoma |
| M663 | Osteosarcoma cells |
| MCF-7 | Human breast cancer |
| MDA-MB-231 | Human breast adenocarcinoma |
| MG-63 | Osteosarcoma cells |
| MIAs | Terpenoid indole compounds |
| MIAs | Monoterpenoid indole compounds |
| MIC | Minimum inhibitory concentration |
| NF-kB | Nuclear factor k-light-chain-enhancer of activated B cells |
| NO | Nitric oxide |
| PANC-1 | Pancreatic cancer |
| PC-3 | Human prostate carcinoma |
| PGE2 | Prostaglandin E2 |
| SAOS-2 | Osteosarcoma cell lines |
| SCC-PKU | Head and neck squamous cell carcinomas |
| SCL-1 | Head and neck squamous cell carcinomas |
| SGC-7901 | Gastric cancer |
| SHG-44 | Human glioma cancer |
| SK-BR-3 | Human breast cancer |
| SK-MEL-2 | Human skin cancer |
| SMMC-7721 | Hepatocellular carcinoma |
| SOSP-9607 | Human Osteosarcoma cell lines |
| SW480 | Human Colon cancer |
| TCA-83 | Head and neck squamous cell carcinomas |
| TNF-α | Tumor necrosis factor-α |
| U251 | Human glioma cancer |
| U2-OS | Osteosarcoma cell lines |
| UMSCC-1 | Head and neck squamous cell carcinomas |